1. STORRE
  2. Senior Management Team
  3. Senior Management Team Journal Articles
Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/36920
Full metadata record
DC FieldValueLanguage
dc.contributor.authorde Paula, Brunoen_UK
dc.contributor.authorCexus, Olivieren_UK
dc.contributor.authorTownsend, Paulen_UK
dc.contributor.authorCrocamo, Susanneen_UK
dc.date.accessioned2025-03-21T01:32:24Z-
dc.date.available2025-03-21T01:32:24Z-
dc.date.issued2025-01en_UK
dc.identifier.urihttp://hdl.handle.net/1893/36920-
dc.description.abstractFirst paragraph: Dear Editor, We recently came across Mei Liu et al meta-analysis, a comprehensive study published in 2023, and wish to discuss a few aspects.en_UK
dc.language.isoenen_UK
dc.publisherElsevier BVen_UK
dc.relationde Paula B, Cexus O, Townsend P & Crocamo S (2025) Zoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast cancer. <i>Asian Journal of Surgery</i>, 48 (1), pp. 566-567. https://doi.org/10.1016/j.asjsur.2024.07.024en_UK
dc.rights© 2024 Asian Surgical Association and Taiwan Society of Coloproctology. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).en_UK
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en_UK
dc.subjectHer2-positive breast canceren_UK
dc.subjectZoledronic aciden_UK
dc.subjectPathological complete response rateen_UK
dc.titleZoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast canceren_UK
dc.typeLetteren_UK
dc.identifier.doi10.1016/j.asjsur.2024.07.024en_UK
dc.identifier.pmid39043484en_UK
dc.citation.jtitleAsian Journal of Surgeryen_UK
dc.citation.issn1015-9584en_UK
dc.citation.volume48en_UK
dc.citation.issue1en_UK
dc.citation.spage566en_UK
dc.citation.epage567en_UK
dc.citation.publicationstatusPublisheden_UK
dc.citation.peerreviewedUnrefereeden_UK
dc.type.statusVoR - Version of Recorden_UK
dc.contributor.funderNational Cancer Institute Colombiaen_UK
dc.author.emailcatherine.stewart@stir.ac.uken_UK
dc.citation.date23/07/2024en_UK
dc.contributor.affiliationUniversity of Surreyen_UK
dc.contributor.affiliationUniversity of Surreyen_UK
dc.contributor.affiliationUniversity of Surreyen_UK
dc.contributor.affiliationBrazilian National Cancer Institute (INCA)en_UK
dc.identifier.isiWOS:001398512900001en_UK
dc.identifier.scopusid2-s2.0-85200848323en_UK
dc.identifier.wtid2087789en_UK
dc.date.accepted2024-07-04en_UK
dcterms.dateAccepted2024-07-04en_UK
dc.date.filedepositdate2025-01-13en_UK
rioxxterms.apcnot requireden_UK
rioxxterms.typeJournal Article/Reviewen_UK
rioxxterms.versionVoRen_UK
local.rioxx.authorde Paula, Bruno|en_UK
local.rioxx.authorCexus, Olivier|en_UK
local.rioxx.authorTownsend, Paul|en_UK
local.rioxx.authorCrocamo, Susanne|en_UK
local.rioxx.projectProject ID unknown|National Cancer Institute Colombia|en_UK
local.rioxx.freetoreaddate2025-03-12en_UK
local.rioxx.licencehttp://creativecommons.org/licenses/by-nc-nd/4.0/|2025-03-12|en_UK
local.rioxx.filename1-s2.0-S1015958424013782-main.pdfen_UK
local.rioxx.filecount1en_UK
local.rioxx.source1015-9584en_UK
Appears in Collections:Senior Management Team Journal Articles

Files in This Item:
File Description SizeFormat 
1-s2.0-S1015958424013782-main.pdfFulltext - Published Version181.77 kBAdobe PDFView/Open


This item is protected by original copyright

View License
Show simple item record


A file in this item is licensed under a Creative Commons License Creative Commons

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.